ADAP - FDA accepts Adaptimmune BLA for afami-cel decision expected by Aug. 4
2024-01-31 18:30:01 ET
More on Adaptimmune
- Adaptimmune Therapeutics plc (ADAP) Q3 2023 Earnings Call Transcript
- Adaptimmune projects sarcoma franchise to deliver US peak year sales up to $400M
- Seeking Alpha’s Quant Rating on Adaptimmune
- Historical earnings data for Adaptimmune
- Financial information for Adaptimmune